Showing results (571-580 of 864) with videos related to
Sort By:
Pageof 87
Current Drug Discovery Technologies|July 3, 2019
Statins as the Controlling Agents for Non-Hodgkin's Lymphomas via Increasing the Casein Kinase 2 Interacting Protein-1: A HypothesisKimia Kazemi, Negin Mozafari, Hajar Ashrafi, et al.Current Drug Discovery Technologies|October 12, 2018
Combiphore (Structure and Ligand Based Pharmacophore) - Approach for the Design of GPR40 Modulators in the Management of DiabetesKrishna A Gajjar, Anuradha K GajjarCurrent Drug Discovery Technologies|March 31, 2023
Exploring the Molecular Structural Requirements of Flavonoids as Beta- Secretase-1 Inhibitors Using Molecular Modeling StudiesUttam A More, Malleshappa N Noolvi, Devendra Kumar, et al.Current Drug Discovery Technologies|March 30, 2021
Effect of Anti-Retroviral Drug Impurity/Related Substances on the CCR5 and/or CXCR4 Receptors Binding Sites to Revise Resistance Mechanisms in the Clinical Implications Using Molecular Docking StudiesRinchi Bora, M R Jeyaprakash, S JubieCurrent Drug Discovery Technologies|August 10, 2020
Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADDWaqar Hussain, Nouman Rasool, Yaser Daanial KhanCurrent Drug Discovery Technologies|June 26, 2012
Past, present and future of nutrigenomics and its influence on drug developmentKenneth LundstromCurrent Drug Discovery Technologies|July 13, 2020
The Toxicity Effect of Echium amoenum on the Liver and Kidney of MiceMozhgan Ghorbani, Atefeh Araghi, Nabi Shariatifar, et al.Current Drug Discovery Technologies|July 31, 2020
Discovery of Traditional Chinese Medicine Derived Compounds as Wild Type and Mutant Plasmodium falciparum Dihydrofolate Reductase Inhibitors: Induced Fit Docking and ADME StudiesOpeyemi Iwaloye, Olusola Olalekan Elekofehinti, Babatomiwa Kikiowo, et al.Current Drug Discovery Technologies|January 29, 2014
Selective cyclooxygenase inhibitors: current statusRavindran Nandakishore, Prasanna R Yalavarthi, Yengala R Kiran, et al.Current Drug Discovery Technologies|August 12, 2022
Predicting the Anticancer Activity of 2-alkoxycarbonylallyl Esters against MDA-MB-231 Breast Cancer - QSAR, Machine Learning and Molecular DockingBabatunde Samuel Obadawo, Oluwatoba Emmanuel Oyeneyin, Adesoji Alani Olanrewaju, et al.Pageof 87